|Partial Close, 5/2009 ||$6.27M|
|Partial Close, 12/2011 ||$18.8M|
|Private Equity, 10/2013 |
New Science Ventures
|Debt, 11/2009 |
|Debt, 11/2010 ||$9.69M|
|Debt, 6/2012 ||$5M|
|Debt, 4/2013 ||$1.81M|
Svelte Medical Systems, Inc. (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Svelte was founded in 2007 by Robert Fischell, ScD, David Fischell, PhD and Tim Fischell, MD with a mission to address key clinical issues in the stent market by improving stent deliverability, reducing cost and dramatically improving the safety of the device compared to currently market products.
Svelte has developed the lowest profile and most deliverable balloon expandable stent in the market, along with technology to create a non-thrombogenic, non-inflammatory Drug Eluting Stent (DES).